Series Title | European Voice |
---|---|
Series Details | 09/01/97, Volume 3, Number 01 |
Publication Date | 09/01/1997 |
Content Type | News |
Date: 09/01/1997 ...under the so-called 'Article 16' procedure of the licensing regulation which gives a member state three months to produce evidence that a biotech-nology product gives cause for health or environmental concerns. If it cannot convince its EU partners, Austria will have to accept the product once the review period is over. The Commission approved the controversial seed at its last meeting of 1996. |
|
Subject Categories | Business and Industry |